IEEE

Assessing Pulmonary Function in ALS using Electrical Impedance Tomography

Abstract: This study aimed to determine an optimal model involving thoracic electrical impedance tomography (EIT) metrics and patient geometric information to best correlate to standard pulmonary ...
Managed Healthcare Executive

Jascayd gets second FDA approval, this time for progressive pulmonary fibrosis

The FDA has approved Jascayd (nerandomilast) as a treatment for a second lung disease, progressive pulmonary fibrosis, following the drug’s initial approval in October 2025 as a treatment for ...
Le Lézard

Savara Resubmits the Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for MOLBREEVI* for the Potential Treatment of Autoimmune Pulmonary ...

Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced today that it has resubmitted the MOLBREEVI BLA to the FDA, with Fujifilm as the ...
Healio

Mortality odds elevated in middle-aged smokers with low vs. high lung function

Having low lung function as a middle-aged smoker without airway obstruction raised the likelihood for all-cause mortality, ...

How Thick Winter Smog And Pollution Impact Interstitial Lung Diseases (ILDs)

Winter smog is not merely an environmental nuisance, it poses a serious health threat to people living with Interstitial Lung Diseases ...